Wednesday, July 8, 2026

pharma · Multiple Myeloma · generalized myasthenia gravis · RNAC

Cartesian Therapeutics

Cartesian Therapeutics trial registry — 13 ClinicalTrials.gov studies with program phase, status, and indication context.

7495 New Horizon Way, Frederick, Maryland 21703, US HQ
2016 Founded
89 Employees
Public company Type
RNAC · NYSE Ticker
Company details
Status
Public
HQ
7495 New Horizon Way, Frederick, Maryland 21703, US
Founded
2016
Employees
89
Programs
12
Drugs
4
Patents
4
Intelligence · Clinical Trials

Cartesian Therapeutics clinical trials

Registry index of 13 ClinicalTrials.gov studies linked to Cartesian Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.

Cartesian Therapeutics trial registry — 13 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Cartesian Therapeutics.

  1. Descartes-08 — Phase 2

    Clinical update
  2. Descartes-08 — Phase 2

    Clinical update
  3. Descartes-08 — Phase 2

    Clinical update
  4. Placebo to Descartes-08, Descartes-08 — Phase 3

    Clinical update
  5. Descartes 30 — Phase 1

    Clinical update
  6. Descartes-25 — Phase 1

    Clinical update
  7. Descartes-15 — Phase 1

    Clinical update
  8. Descartes-11 — Phase 2

    Clinical update

Trial registry

13 studies